152 related articles for article (PubMed ID: 36939965)
1. Urinary BLACAT1 as a non-invasive biomarker for bladder cancer.
El Sharkawi FZ; El Sabah M; Atya HB; Khaled HM
Mol Biol Rep; 2023 May; 50(5):4339-4345. PubMed ID: 36939965
[TBL] [Abstract][Full Text] [Related]
2. Evaluation on the diagnostic and prognostic values of long non-coding RNA BLACAT1 in common types of human cancer.
Chen X; Dai M; Zhu H; Li J; Huang Z; Liu X; Huang Y; Chen J; Dai S
Mol Cancer; 2017 Oct; 16(1):160. PubMed ID: 29037201
[TBL] [Abstract][Full Text] [Related]
3. LncRNA BLACAT1 May Serve as a Prognostic Predictor in Cancer: Evidence from a Meta-Analysis.
Lu H; Liu H; Yang X; Ye T; Lv P; Wu X; Ye Z
Biomed Res Int; 2019; 2019():1275491. PubMed ID: 31061820
[TBL] [Abstract][Full Text] [Related]
4. Cell-free lncRNA expression signatures in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
Du L; Duan W; Jiang X; Zhao L; Li J; Wang R; Yan S; Xie Y; Yan K; Wang Q; Wang L; Yang Y; Wang C
J Cell Mol Med; 2018 May; 22(5):2838-2845. PubMed ID: 29516641
[TBL] [Abstract][Full Text] [Related]
5. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
Dong Z; Wang Y
Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA BLACAT1 promotes cell proliferation, migration and invasion in cervical cancer through activation of Wnt/β-catenin signaling pathway.
Wang CH; Li YH; Tian HL; Bao XX; Wang ZM
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3002-3009. PubMed ID: 29863244
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA Bladder Cancer Associated Transcript 1 Promotes the Proliferation, Migration, and Invasion of Nonsmall Cell Lung Cancer Through Sponging miR-144.
Ye JR; Liu L; Zheng F
DNA Cell Biol; 2017 Oct; 36(10):845-852. PubMed ID: 28885863
[TBL] [Abstract][Full Text] [Related]
8. Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
Avgeris M; Tsilimantou A; Levis PK; Rampias T; Papadimitriou MA; Panoutsopoulou K; Stravodimos K; Scorilas A
Carcinogenesis; 2019 Aug; 40(8):965-974. PubMed ID: 30815670
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA BLACAT1, a novel promising biomarker and regulator of human cancers.
Zhu M; Li X; Zhu S; Li P; Min L; Zhang S
Biomed Pharmacother; 2020 Dec; 132():110808. PubMed ID: 33113422
[TBL] [Abstract][Full Text] [Related]
10. Expression and Diagnostic Value of lncRNA BLACAT1 in Peripheral Blood of Patients with Acute Myeloid Leukemia.
Wu X; Wang J; Li D; Xu Z
Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255290
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of serum exosomal LncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer.
Zhang S; Du L; Wang L; Jiang X; Zhan Y; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Shi Y; Wang C
J Cell Mol Med; 2019 Feb; 23(2):1396-1405. PubMed ID: 30467945
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNAs, ENST00000598996 and ENST00000524265, are correlated with favorable prognosis and act as potential tumor suppressors in bladder cancer.
Shen C; Wang Y; Wu Z; Da L; Gao S; Xie L; Qie Y; Wang Y; Zhang Z; Tian D; Hu H
Oncol Rep; 2020 Nov; 44(5):1831-1850. PubMed ID: 33000254
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and Clinicopathological Significance of Long Non-Coding RNA BLACAT1 in Cancer: An Updated Meta-Analysis and TCGA Data Review.
Wu T; Wang Q; Ding M; Zhu X; Wu Y
Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180447
[TBL] [Abstract][Full Text] [Related]
15. BLACAT1 is negatively associated with prognosis in patients with NSCLC and inhibits cell progression, metastasis and epithelial-mesenchymal transition through down-regulating Wnt/β-catenin signaling pathway.
Xu R; Cao XR; Zhang BQ; Wang JL; Wang L; Sun WQ
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6217-6225. PubMed ID: 31364123
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer.
Wu S; Nitschke K; Worst TS; Fierek A; Weis CA; Eckstein M; Porubsky S; Kriegmair M; Erben P
J Exp Clin Cancer Res; 2020 Dec; 39(1):288. PubMed ID: 33334367
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic roles of lncRNA BLACAT1 and its related mechanisms in human cancers.
Han W; Yu F; Guan W
Biomed Pharmacother; 2020 Oct; 130():110632. PubMed ID: 34321169
[TBL] [Abstract][Full Text] [Related]
18. LncRNA PCAT6: A potential biomarker for diagnosis and prognosis of bladder cancer.
Zhang D; Du D; Yi S; Li X
Ann Diagn Pathol; 2020 Dec; 49():151642. PubMed ID: 33142195
[TBL] [Abstract][Full Text] [Related]
19. LncRNA BLACAT1 Promotes Proliferation, Migration and Invasion of Prostate Cancer Cells via Regulating miR-29a-3p/DVL3 Axis.
Liao B; Chen S; Li Y; Yang Z; Yang Y; Deng X; Ke S
Technol Cancer Res Treat; 2021; 20():1533033820972342. PubMed ID: 33641528
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer Progression.
Piao XM; You C; Byun YJ; Kang HW; Noh J; Lee J; Lee HY; Kim K; Kim WT; Yun SJ; Lee SC; Kang K; Kim YJ
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
